Sunnyvale, California, United States Life Science Angels is the famous VC, which was founded in 2004. The main department of described VC is located in the Sunnyvale. The fund was located in North America if to be more exact in United States.
The fund is constantly included in 2-6 investment rounds annually. The common things for fund are deals in the range of 5 - 10 millions dollars. When the investment is from Life Science Angels the average startup value is 1-5 millions dollars. The real fund results show that this VC is 4 percentage points less often commits exit comparing to other companies. The top activity for fund was in 2007. Despite it in 2019 the fund had an activity. Comparing to the other companies, this Life Science Angels performs on 13 percentage points less the average number of lead investments. The top amount of exits for fund were in 2018.
The fund was created by Allan May. Besides them, we counted 18 critical employees of this fund in our database.
The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the most successful fund investment fields, there are Medical Device, Health Diagnostics. Among the most popular portfolio startups of the fund, we may highlight Vaxart, Verdezyne, OncoHealth. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Life Science Angels, startups are often financed by Tech Coast Angels, Sand Hill Angels, Kentucky Science and Technology Corporation (KSTC). The meaningful sponsors for the fund in investment in the same round are Tech Coast Angels, Sand Hill Angels, The Angels' Forum. In the next rounds fund is usually obtained by Tech Coast Angels, Sand Hill Angels, OVP Venture Partners.
| Fund Name | Location |
| Bruker BioSpin | Billerica, Massachusetts, United States |
| Chart Venture Partners | New York, New York, United States |
| Cypher Holdings | - |
| Essential Capital | Beijing, China, Haidian |
| kCash Foundation | - |
| MegaThrust Capital Berhad | - |
| Newmont | Colorado, Denver, United States |
| Nidus Partners | Missouri, St Louis, United States |
| Nobska Point Capital | Boston, Massachusetts, United States |
| Panasonic Information Systems | Japan, Osaka, Osaka Prefecture |
| Seed X Liechtenstein | Liechtenstein, Schaan, Schaan |
| Shanghai Hua Hong International | - |
| Signify | Amsterdam, Noord-Holland, The Netherlands |
| Startup Holding | Latvia, Riga, Vidzeme |
| Suda Tiangong | China, Jiangsu, Suzhou |
| Washington Post | District of Columbia, United States, Washington |
| Wolff Center for Entrepreneurship | Houston, Texas, United States |
| Woodford Investment Management | Oxford, Oxfordshire, United Kingdom |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Pelvital | $2M | 22 Apr 2024 | Minneapolis, Minnesota, United States | ||
Neurava | $2M | 03 Apr 2024 | - | ||
Avisi Technologies | $6M | 01 Oct 2023 | Philadelphia, Pennsylvania, United States | ||
Astrocyte Pharmaceuticals | $6M | 18 Aug 2023 | Cambridge, Massachusetts, United States | ||
InnoSIGN | $8M | 22 Mar 2022 | Eindhoven, Noord-Brabant, The Netherlands | ||
Avisi Technologies | $1M | 01 Sep 2021 | Philadelphia, Pennsylvania, United States | ||
Allyx Therapeutics | $7M | 01 Jun 2021 | New Haven, New York, United States | ||
Astrocyte Pharmaceuticals | $6M | 03 May 2021 | Cambridge, Massachusetts, United States | ||
Strategikon Pharma | 22 Apr 2021 | San Rafael, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Pelvital | $2M | 22 Apr 2024 | Minneapolis, Minnesota, United States | ||
Neurava | $2M | 03 Apr 2024 | - | ||
Avisi Technologies | $6M | 01 Oct 2023 | Philadelphia, Pennsylvania, United States | ||
Astrocyte Pharmaceuticals | $6M | 18 Aug 2023 | Cambridge, Massachusetts, United States | ||
InnoSIGN | $8M | 22 Mar 2022 | Eindhoven, Noord-Brabant, The Netherlands | ||
Avisi Technologies | $1M | 01 Sep 2021 | Philadelphia, Pennsylvania, United States | ||
Allyx Therapeutics | $7M | 01 Jun 2021 | New Haven, New York, United States | ||
Astrocyte Pharmaceuticals | $6M | 03 May 2021 | Cambridge, Massachusetts, United States | ||
Strategikon Pharma | 22 Apr 2021 | San Rafael, California, United States |
